Moderate riskFDA DrugClass III

ANI Pharmaceuticals hydroxyzine recalled for foreign substance

ANI Pharmaceuticals is recalling hydroxyzine hydrochloride oral solution (10 mg/5 mL, 473 mL bottles) due to the presence of a foreign substance in one lot. The affected product was distributed nationwide. No injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if you have hydroxyzine oral solution lot S25133A (NDC 70954-912-10).
  2. Stop using the product and contact your pharmacy or healthcare provider.
  3. Do not flush or throw away the medication; ask your pharmacist how to safely dispose of it.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint), Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC: 70954-912-10
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
6564 bottles
Illnesses reported
None reported
Manufactured in
210 W Main St, N/A, Baudette, MN, United States
Classification
Class III
Recall number
D-0619-2026

In the FDA's words

Description
hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint), Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC: 70954-912-10 Presence of foreign substance Lot S25133A Distribution: Nationwide in the USA Affected quantity: 6564 bottles
Hazard
Presence of foreign substance

Related topics

ParticulateDrugsSold nationwideMore from FDA Drug